Pre-exposure prophylaxis (PrEP)


PrEP stands for pre-exposure prophylaxis and refers to the use of HIV antiretroviral medications by an HIV-negative person to reduce their risk of getting HIV.


CTAC has produced a number of PrEP resources and advocates for increased access to PrEP.


CTAC Talks! PrEP Access in Canada

Policy researcher and PrEP expert Jack Mohr looks at the current state of pre-exposure prophylaxis (PrEP) access in Canada, what we can expect next, and the role of healthcare providers and government. This video was made in July 2017.


CTAC Talks! PrEP: A Game Changer for HIV Prevention in Canada?

CTAC’s expert guests discuss the impact of Pre-Exposure Prophylaxis, or PrEP, which involves the use of antiretroviral medications by an HIV-negative person to prevent possible HIV transmission. This video was made in February 2017.


Service Provider Guide: Providing HIV PrEP: Steps to Patient Engagement


Policy Brief 1: Following the Regulatory Pathway for Truvada as PrEP


Policy Brief 2: Consensus to Action: Next Steps for  equitable access to PrEP in Canada  


PrEP Workshop

Learn about policy barriers and ways to support broader access to PrEP in Canada.


This one and a half hour webinar or presentation is suitable for service providers, health professionals, policy researchers,  and anyone interested in the subject area.


To find out more please contact Rounak on 437-222-2822, ext 233 or Rounak[at]


CTAC Patient Group Input Submission on Truvada as PrEP
CTAC Patient Group Input Submission on Truvada as PrEP – webinar and slides